{"gene":"MITF","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":2006,"finding":"MITF directly transcriptionally activates the DIAPH1 gene encoding the formin Dia1, which promotes actin polymerization. Low MITF levels reduce Dia1 expression, reorganize the actin cytoskeleton, and increase ROCK-dependent invasiveness; high MITF expression decreases invasiveness. Additionally, MITF regulation of Dia1 controls p27(Kip1)-dependent G1 arrest, linking MITF to both invasiveness and proliferation control.","method":"Transcriptional reporter assays, siRNA knockdown, overexpression in melanoma cells, cell invasion assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean KD/OE with defined cellular phenotype, multiple orthogonal readouts (actin reorganization, p27 degradation, ROCK-dependent invasion) in a single focused study","pmids":["17182868"],"is_preprint":false},{"year":2005,"finding":"MITF acts as an anti-proliferative transcription factor by directly activating the p21(Cip1)/CDKN1A cyclin-dependent kinase inhibitor gene, inducing G1 cell-cycle arrest. Cooperation between MITF and the retinoblastoma protein Rb1 potentiates MITF-mediated transcriptional activation, and this cooperation is disrupted by melanoma-associated mutations in INK4a or BRAF.","method":"Transcriptional reporter assays, ChIP, loss-of-function/gain-of-function in melanocytes and melanoma cells, cell cycle analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal functional assays, ChIP validation, multiple orthogonal methods, replicated concept across multiple studies","pmids":["15716956"],"is_preprint":false},{"year":2004,"finding":"MITF is subject to SUMO modification at conserved lysine residues within SUMO consensus sites. Mutation of these sites significantly affects transcriptional activity of MITF but does not alter dimerization, DNA binding, stability, or nuclear localization. The functional consequences of sumoylation depend on promoter context (synergy control model): differences in transcriptional activity between wild-type and non-sumoylatable MITF are seen only on promoters with multiple MITF binding sites.","method":"SUMO modification assays, mutagenesis of sumoylation sites, luciferase reporter assays, dimerization and DNA-binding assays in vitro","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with in vitro binding assays and reporter assays, multiple orthogonal methods in a single focused study","pmids":["15507434"],"is_preprint":false},{"year":2011,"finding":"A germline missense substitution in MITF (E318K) located within a SUMO consensus site severely impairs SUMOylation of MITF. The SUMOylation-defective Mi-E318K mutant shows enhanced MITF protein binding to the HIF1A promoter, increased transcriptional activity, and a global increase in MITF-occupied loci compared to wild-type MITF, consistent with a gain-of-function mechanism.","method":"SUMO modification assays, ChIP, gene expression profiling, clonogenicity/migration/invasion assays in cell lines","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — biochemical SUMO assay, ChIP, functional cellular assays, two independent publications (PMID 22012259 and 22080950) confirming E318K impairs sumoylation","pmids":["22012259","22080950"],"is_preprint":false},{"year":2004,"finding":"MITF directly binds the INK4A (CDKN2A) promoter, activates p16(Ink4a) mRNA and protein expression, induces retinoblastoma protein hypophosphorylation, and thereby triggers cell cycle arrest. MITF-driven INK4A activation was required for efficient melanocyte differentiation, linking melanocyte differentiation to cell cycle exit through MITF.","method":"ChIP, luciferase reporter assays, MITF overexpression/knockdown, Western blot for Rb phosphorylation, differentiation assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP validation plus functional rescue/loss-of-function with defined cell cycle readout, multiple orthogonal methods","pmids":["15623583"],"is_preprint":false},{"year":2001,"finding":"M-CSF/macrophage colony-stimulating factor induces phosphorylation of Mitf and TFE3 via a conserved MAPK consensus site, triggering their recruitment of the coactivator p300. An unphosphorylatable Mitf mutant at the MAPK consensus serine specifically fails to support formation of multinucleated osteoclasts, mimicking the defect in Mitf(mi/mi) mice, placing Mitf downstream of M-CSF signaling in osteoclast development.","method":"Phosphorylation assays, co-immunoprecipitation with p300, mutagenesis, osteoclast differentiation assays in Mitf(mi/mi) bone marrow cultures","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis of phosphorylation site with clear phenotypic readout, co-IP with p300, functional reconstitution in osteoclast model","pmids":["11684011"],"is_preprint":false},{"year":2007,"finding":"MITF and PU.1 co-occupy promoters of osteoclast target genes (e.g., cathepsin K, acid phosphatase 5) in bone marrow-derived precursors in response to CSF-1. RANKL + CSF-1 signaling recruits MAPK-phosphorylated forms of MITF, p38 MAPK, and SWI/SNF chromatin-remodeling complexes to these promoters and markedly increases gene expression. NFATc1 is subsequently recruited to these complexes during terminal osteoclast differentiation.","method":"ChIP, co-immunoprecipitation, genetic analysis in Mitf and Pu.1 mutant mice, gene expression assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP at endogenous promoters, reciprocal co-IP, genetic mouse models, multiple orthogonal methods","pmids":["17403683"],"is_preprint":false},{"year":2003,"finding":"MITF directly transcriptionally regulates the melanoma diagnostic antigens SILV/PMEL17/GP100 and MLANA/MART1. Both gene promoters contain conserved MITF consensus DNA sequences that are bound by MITF in vitro (EMSA) and in vivo (ChIP), and up- or down-regulation of MITF produces corresponding changes in endogenous SILV and MLANA expression.","method":"EMSA, ChIP, luciferase reporter assays, siRNA knockdown and overexpression of MITF in melanoma cells","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP and EMSA plus functional reporter assays and endogenous gene modulation, multiple orthogonal methods","pmids":["12819038"],"is_preprint":false},{"year":2006,"finding":"c-Met (HGF receptor) is a direct transcriptional target of MITF. MITF binds the human c-Met promoter in vivo (ChIP) and adenovirally expressed MITF modulates endogenous c-Met protein levels in melanocytes. Disruption of MITF blocked HGF-dependent increases in c-Met mRNA/protein, indicating HGF regulates its own receptor levels via MITF. Dominant-negative inhibition of MITF resulted in resistance to HGF-dependent matrix invasion.","method":"ChIP, adenoviral overexpression, MITF dominant-negative constructs, matrix invasion assays, Western blot","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP and functional genetic manipulation with defined invasion phenotype, multiple orthogonal methods","pmids":["16455654"],"is_preprint":false},{"year":2018,"finding":"BRAF/MAPK signaling phosphorylates the melanocyte MITF-M isoform, which primes for subsequent phosphorylation by GSK3 (downstream of PI3K and Wnt). Dual phosphorylation (but not monophosphorylation) promotes MITF nuclear export by activating a previously unrecognized hydrophobic export signal. Non-melanocyte MITF isoforms show poor regulation by MAPK but their export is controlled by mTOR.","method":"Phosphorylation mapping, mutagenesis, nuclear export assays, kinase inhibitor treatments, mass spectrometry","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — mutagenesis combined with nuclear export assays and MS-based phosphorylation mapping, multiple orthogonal methods","pmids":["30150413"],"is_preprint":false},{"year":2015,"finding":"MITF expression drives endolysosomal biogenesis in melanoma cells by upregulating lysosomal genes. This leads to a marked increase in multivesicular body (MVB) formation that sequesters the Wnt destruction complex (Axin1, phospho-LRP6, phospho-β-catenin, GSK3) upon Wnt stimulation, enhancing Wnt signaling. MITF protein is stabilized by Wnt signaling through novel C-terminal GSK3 phosphorylation sites, generating a positive feedback loop.","method":"Tetracycline-inducible MITF expression, immunofluorescence for late endosomal proteins, Wnt reporter assays, phosphorylation mapping, colocalization studies","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — inducible expression system, vesicle characterization, Wnt reporter assays, multiple orthogonal methods in one study","pmids":["25605940"],"is_preprint":false},{"year":2019,"finding":"MITF binds the CLEAR-box element in the promoters of lysosomal and autophagosomal genes in melanocytes and melanoma cells. Crystal structure of MITF bound to the CLEAR-box reveals that the palindromic nature of this motif induces symmetric MITF homodimer binding. Depletion of MITF attenuates starvation-induced autophagy, while overexpression increases autophagosome numbers but is insufficient to induce autophagic flux.","method":"Crystal structure determination, ChIP-seq, MITF knockdown and overexpression, autophagy flux assays","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 / Moderate — crystal structure with functional ChIP validation and loss/gain-of-function autophagy phenotype, multiple orthogonal methods","pmids":["30705290"],"is_preprint":false},{"year":2004,"finding":"In mast cells stimulated via gp130 receptor, MITF is phosphorylated at S409. This phosphorylation of MITF leads to PIAS3 dissociation from MITF and association of PIAS3 with STAT3, mobilizing PIAS3 from MITF to STAT3. In MITF(di/di) mice lacking the Zip domain (the PIAS3-binding domain of MITF), mRNA levels of genes regulated by either MITF or STAT3 are downregulated.","method":"Phosphorylation assays, co-immunoprecipitation, genetic analysis in MITF(di/di) mice, gene expression assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — co-IP demonstrating protein complex dynamics with phosphorylation, genetic validation in mutant mice, multiple orthogonal methods","pmids":["15572665"],"is_preprint":false},{"year":2018,"finding":"The bHLH-Zip domain of MITF-M contains three karyophilic signals (residues 197–206, 214–217, 255–265). Neither DNA binding nor dimerization is required for nuclear localization of MITF-M. Dimerization-deficient MITF-M mutants show significantly reduced stability in melanoma cells compared to wild-type protein, indicating the bHLH-Zip domain modulates both subcellular localization and protein stability.","method":"Mutational analysis of nuclear localization signals, structural characterization, nuclear localization assays, protein stability assays in melanoma cells","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic mutagenesis with structural analysis, but single lab study","pmids":["29938923"],"is_preprint":false},{"year":2011,"finding":"KIT signaling in mast cells markedly upregulates MITF protein without significantly changing MITF mRNA levels, indicating posttranscriptional regulation. KIT signaling downregulates miR-539 and miR-381, miRNAs that repress MITF expression through conserved binding sites in the MITF 3'-UTR. MITF is required for the proliferative phenotype in mast cells, as shRNA knockdown inhibited colony-forming activity.","method":"miRNA array, luciferase 3'-UTR reporter assays, miRNA overexpression, shRNA knockdown, colony-forming assays","journal":"Blood","confidence":"High","confidence_rationale":"Tier 2 / Moderate — 3'-UTR reporter validation of miRNA targeting, functional knockdown with colony formation readout, multiple orthogonal methods","pmids":["21273305"],"is_preprint":false},{"year":2016,"finding":"MITF directly activates BPTF gene transcription by binding to the BPTF promoter (validated by ChIP), and MITF overexpression upregulates BPTF and BPTF-regulated genes including BCL2. Suppression of cell growth mediated by MITF silencing is rescued by overexpression of BPTF cDNA, placing BPTF downstream of MITF in the pro-survival signaling cascade.","method":"ChIP, luciferase reporter assays, MITF overexpression and shRNA knockdown, rescue experiment with BPTF cDNA","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP combined with functional rescue experiment and reporter assays, multiple orthogonal methods","pmids":["27185926"],"is_preprint":false},{"year":2012,"finding":"PGC-1α and PGC-1β coactivators are critical for α-MSH–induced MITF expression in melanocytes. α-MSH signaling strongly induces PGC-1α expression and stabilizes both PGC-1α and PGC-1β proteins, which in turn directly activate the MITF promoter. Inhibition of PGC-1α and PGC-1β blocks α-MSH–mediated induction of MITF and melanogenic genes.","method":"PGC-1 overexpression and siRNA knockdown, MITF promoter reporter assays, α-MSH stimulation, gene expression analysis, transgenic animals","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — promoter reporter assays combined with in vivo transgenic validation and loss-of-function, multiple orthogonal methods","pmids":["23201126"],"is_preprint":false},{"year":2016,"finding":"AKT phosphorylates MITF at Serine 510. Phosphorylated MITF-S510 enhances its affinity for TP53 and promotes CDKN1A (p21) expression. Non-phosphorylated MITF promotes TYR (tyrosinase) expression instead, revealing a bifunctional switch in MITF target gene regulation depending on AKT activity.","method":"Kinase assays, co-immunoprecipitation, mutagenesis of S510, luciferase reporter assays, Western blot","journal":"The international journal of biochemistry & cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — co-IP and mutagenesis establishing phosphorylation-dependent binding, single lab, single study","pmids":["27702651"],"is_preprint":false},{"year":2019,"finding":"MITF directly represses its own transcription (autorepression) and directly regulates SDHB to control the TCA cycle and suppress pseudo-hypoxia. Under hypoxia, MITF is transiently upregulated by HIF1α and co-regulates a subset of HIF targets including VEGFA.","method":"ChIP-seq, gene expression analysis under hypoxia, knockdown/overexpression of MITF, metabolite measurement","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP-seq and functional gene regulation studies, single lab, single publication","pmids":["31207090"],"is_preprint":false},{"year":2017,"finding":"UCHL1 negatively regulates MITF protein stability by binding to ubiquitinated MITF and promoting its proteasomal degradation. UCHL1 knockdown upregulates MITF protein (but not mRNA), and proteasome inhibitor MG132 prevents UCHL1-mediated MITF reduction. UCHL1 overexpression suppresses MITF-dependent melanogenesis genes.","method":"siRNA knockdown, adenoviral overexpression, proteasome inhibitor treatment, co-immunoprecipitation of ubiquitinated MITF, Western blot","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — co-IP with ubiquitinated MITF and proteasome inhibitor rescue, single lab, single study","pmids":["28392346"],"is_preprint":false},{"year":2016,"finding":"Androgen receptor (AR) promotes MITF protein degradation through modulation of the miRNA-539-3p/USP13 signaling axis; AR reduces de-ubiquitination of MITF by decreasing USP13 activity via miRNA-539-3p, leading to decreased MITF levels, which shifts the MITF/AXL balance and promotes melanoma cell invasion. Restoring MITF reverses AR-enhanced invasion.","method":"AR and USP13 manipulation, MITF protein stability assays, ubiquitination assays, invasion assays, rescue experiments","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ubiquitination and stability assays with functional rescue, single lab, single study","pmids":["27869170"],"is_preprint":false},{"year":2021,"finding":"MITF directly transcriptionally activates ADAM10 (a sheddase that cleaves MICA/B NK cell ligands), as established by ChIP-seq, ChIP-qPCR, CRISPR-Cas9 editing of the MITF binding site, and luciferase reporter assays. High MITF-expressing melanoma cells escape NK cell killing by shedding MICA/B via ADAM10, whereas MITF-low cells are susceptible to NK-mediated killing.","method":"ChIP-seq, ChIP-qPCR, CRISPR-Cas9 genome editing, luciferase reporter assays, flow cytometry, NK cytotoxicity assays","journal":"Journal of experimental & clinical cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP with CRISPR-Cas9 editing of binding site and functional NK killing assay, multiple rigorous orthogonal methods","pmids":["33789714"],"is_preprint":false},{"year":2021,"finding":"MITF directly represses the expression of genes associated with extracellular matrix (ECM) remodeling, focal adhesion pathways, and EMT regulators such as CDH2 in melanoma cells. MITF knockdown increases the number of focal adhesion points, a feature of drug-resistant melanomas. These effects are reversible, consistent with the MITF rheostat model.","method":"MITF knockdown, ChIP-seq for direct repression targets, focal adhesion quantification, gene expression profiling, morphology analysis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — ChIP-seq confirming direct binding at repressed genes, multiple orthogonal phenotypic readouts","pmids":["33438577"],"is_preprint":false},{"year":2022,"finding":"TFAP2 paralogs (TFAP2A and TFAP2C) are required for MITF binding and chromatin accessibility at a subset of enhancers near pigmentation and proliferation genes in melanoma cells. Deletion of TFAP2A and TFAP2C abolishes MITF chromatin binding at co-operative enhancers, reduces H3K27Ac marks, and impairs MITF-driven activation of pigmentation genes, revealing TFAP2 as a pioneer factor for MITF.","method":"TFAP2A/C knockout, ChIP-seq for MITF and TFAP2A, ATAC-seq for chromatin accessibility, H3K27Ac and H3K27Me3 ChIP-seq, gene expression analysis","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — combinatorial ChIP-seq and ATAC-seq in knockout cells with multiple orthogonal epigenomic methods","pmids":["35580127"],"is_preprint":false},{"year":2020,"finding":"STAT3 suppresses MITF transcription through induction of CEBP family member transcription factors (CEBPa/b), which bind to the MITF enhancer region and silence the MITF locus. ATAC-seq confirmed CEBPa/b binding at the MITF enhancer causes epigenetic silencing. Loss of STAT3 in mouse melanoma leads to upregulation of MITF and reduced metastasis.","method":"Conditional Stat3 knockout in mouse melanoma, whole-genome expression profiling, ATAC-seq, 3D melanoma models, CEBP ChIP-seq","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic knockout combined with ATAC-seq and transcriptomics, multiple orthogonal methods","pmids":["33323974"],"is_preprint":false},{"year":2018,"finding":"MITF-MIR211 constitutes a feed-forward autophagy amplification loop. Under stress (starvation or mTOR inhibition), MITF translocates to the nucleus and upregulates MIR211. MIR211 directly targets RICTOR (an mTORC2 component), inhibiting the mTORC1 pathway, which further stimulates MITF nuclear translocation, completing a positive feedback loop that sustains autophagic activity.","method":"mTOR inhibition and starvation assays, MITF nuclear translocation imaging, MIR211 overexpression, luciferase 3'-UTR reporter assay for RICTOR, autophagy flux assays","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — 3'-UTR reporter and functional assays, single lab, single study","pmids":["30290719"],"is_preprint":false},{"year":2019,"finding":"p300 histone acetyltransferase directly controls MITF transcription through histone acetylation within proximal MITF gene regulatory regions in melanoma cells. Targeted chemical inhibition of p300 acetyltransferase activity suppresses MITF expression and reduces melanoma cell proliferation. FOXM1 was identified as a key downstream effector of the p300-MITF axis.","method":"p300 genetic and chemical inhibition, ChIP for histone acetylation at MITF locus, gene expression analysis, proliferation assays","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP validation of p300-dependent histone acetylation at MITF locus, single lab, single study","pmids":["30910803"],"is_preprint":false},{"year":2009,"finding":"Zeb1 transcription factor binds the Mitf-A promoter in vivo (ChIP) and represses Mitf expression. Heterozygous Zeb1 mutation or shRNA knockdown prevents Mitf repression during RPE dedifferentiation, thereby maintaining Mitf expression and pigmented epithelial morphology. This identifies a regulatory axis linking cell-cell contact signals to Mitf via Zeb1.","method":"ChIP at Mitf-A promoter, Zeb1 heterozygous mouse model, lentiviral shRNA knockdown, RT-PCR, cell morphology analysis","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating Zeb1 occupancy at Mitf promoter in vivo with genetic validation, moderate evidence","pmids":["19515996"],"is_preprint":false},{"year":2004,"finding":"STAT3 and MITF cooperatively bind and upregulate the c-fos promoter in NIH-3T3 cells, leading to anchorage-independent growth (cellular transformation). ChIP confirmed both STAT3 and MITF bind the c-fos promoter, and dominant-negative AP-1 (c-fos/c-jun) suppressed transformation by STAT3C + MITF.","method":"Retroviral cDNA library screen, promoter luciferase assays, ChIP, soft-agar colony assays, dominant-negative AP-1 suppression","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and functional reporter assays with rescue experiment, single lab, moderate strength","pmids":["14737107"],"is_preprint":false},{"year":2017,"finding":"MITF directly regulates the ABCB5 transporter gene, with β-catenin acting as a key activator and co-factor for MITF at the ABCB5 locus. ABCB5 expression is primarily associated with melanoma cells exhibiting differentiation markers (MITF-high state), contrary to its previous characterization as a dedifferentiated stem cell marker.","method":"ChIP, β-catenin co-activation assays, gene expression analysis in melanoma cell lines","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP validation, single lab, single study","pmids":["31595650"],"is_preprint":false},{"year":2017,"finding":"The Mediator subunit MED23 controls MITF expression by modulating a distal MITF enhancer. Loss of Med23 impairs pigmentation in melanocyte lineage cells and in zebrafish, and enhances nucleotide excision repair (NER) by de-repressing NER factor expression, revealing that the MED23/MITF axis couples DNA repair to pigmentation.","method":"Med23 knockout, MITF enhancer reporter assays, ChIP for NER factors, zebrafish pigmentation rescue, UV DNA damage assays","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic knockout with enhancer reporter and in vivo zebrafish validation, multiple orthogonal methods","pmids":["28834744"],"is_preprint":false},{"year":2021,"finding":"BMAL1 (circadian clock protein) binds the promoter region of MITF and transcriptionally regulates its expression in a rhythmic (24-hr periodicity) manner. BMAL1-driven MITF expression positively influences melanin synthesis and BMAL1 overexpression increases melanin levels that protect melanoma cells from UVB-mediated DNA damage.","method":"Circadian synchronization, ChIP at MITF promoter, BMAL1 overexpression, melanin quantification, UVB damage assays","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — ChIP validation and functional overexpression, single lab, single study","pmids":["34160901"],"is_preprint":false},{"year":2005,"finding":"MITF splice isoforms containing exon 6a (the alternatively spliced hexapeptide upstream of the DNA-binding basic domain) have stronger inhibitory effects on DNA synthesis than isoforms lacking exon 6a. The anti-proliferative activity of (+)MITF depends on the aminoterminus and is modulated by serine-73 phosphorylation, and is not dependent on direct E-box binding.","method":"BrdU incorporation assays, FACS cell cycle analysis, transient transfection of MITF isoform mutants, mutagenesis of phosphorylation sites","journal":"Pigment cell research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mutagenesis combined with functional cell cycle assays, but single lab","pmids":["16162175"],"is_preprint":false},{"year":1997,"finding":"Ectopic MITF expression converts NIH/3T3 fibroblasts into cells with melanocyte characteristics (dendritic morphology, tyrosinase, TRP-1 expression), demonstrating MITF's instructive role in melanocyte differentiation. WS2-associated truncating mutations in MITF lose DNA-binding activity and fail to transactivate the tyrosinase promoter, but do not show dominant-negative effects on wild-type MITF activity, supporting haploinsufficiency as the disease mechanism.","method":"Transfection of MITF and mutants into NIH/3T3 fibroblasts, melanocyte marker expression, DNA-binding assays, luciferase reporter assays","journal":"Pigment cell research","confidence":"High","confidence_rationale":"Tier 2 / Strong — ectopic expression with differentiation marker readout and functional characterization of disease mutants, foundational study confirmed by multiple later papers","pmids":["9170159"],"is_preprint":false}],"current_model":"MITF is a bHLH-Zip transcription factor that functions as a master regulator of the melanocyte lineage by directly activating or repressing target gene promoters through E-box/CLEAR-box binding; its activity is tightly controlled by post-translational modifications including MAPK-primed GSK3 phosphorylation (triggering nuclear export via a hydrophobic export signal), SUMOylation at a conserved ΨKXE site (modulating transcriptional synergy at multi-site promoters via synergy control), AKT phosphorylation at S510 (switching target specificity toward TP53-CDKN1A), S409 phosphorylation (triggering PIAS3 dissociation and redistribution to STAT3), M-CSF/MAPK phosphorylation (recruiting the p300 coactivator for osteoclast gene expression), and ubiquitin-proteasome-mediated degradation regulated by UCHL1 and USP13; MITF drives cell cycle exit by transcriptionally activating p21(Cip1) and p16(INK4A), controls invasiveness by activating the formin DIAPH1/Dia1, regulates lysosomal biogenesis and starvation-induced autophagy through CLEAR-element target genes and a MITF-MIR211 feed-forward loop, escapes innate immune killing via direct transactivation of ADAM10, and requires TFAP2 paralogs as pioneer factors for chromatin access at a subset of its target enhancers."},"narrative":{"mechanistic_narrative":"MITF is a basic-helix-loop-helix leucine-zipper (bHLH-Zip) transcription factor that acts as a master regulator of the melanocyte lineage and a broader rheostat of cell state, capable of instructively converting fibroblasts into pigment-producing cells with melanocyte morphology and marker expression [PMID:9170159]. It binds E-box/CLEAR-box consensus sequences as a homodimer—the palindromic CLEAR-box inducing symmetric dimer binding [PMID:30705290]—to directly activate melanocyte differentiation genes including SILV/PMEL17 and MLANA [PMID:12819038], the receptor c-Met [PMID:16455654], and the transporter ABCB5 in cooperation with β-catenin [PMID:31595650]. MITF couples differentiation to cell-cycle exit by directly activating the CDK inhibitors p21(Cip1)/CDKN1A (potentiated by Rb1) and p16(INK4A), driving Rb hypophosphorylation and G1 arrest [PMID:15716956, PMID:15623583], and controls invasiveness by activating the formin DIAPH1/Dia1 to remodel the actin cytoskeleton and limit ROCK-dependent invasion [PMID:17182868] while directly repressing ECM-remodeling and EMT genes such as CDH2 [PMID:33438577], consistent with a reversible rheostat model of melanoma phenotype switching. Beyond pigment cells, MITF directs lysosomal/autophagosomal biogenesis through CLEAR-box targets and sustains starvation-induced autophagy via a MITF-MIR211-RICTOR feed-forward loop [PMID:30705290, PMID:30290719], promotes endolysosomal sequestration of the Wnt destruction complex to amplify Wnt signaling [PMID:25605940], and functions downstream of M-CSF/RANKL signaling in osteoclast differentiation by cooperating with PU.1, NFATc1 and SWI/SNF [PMID:11684011, PMID:17403683]. MITF activity is governed by an extensive post-translational and transcriptional control network: SUMOylation at a conserved consensus site tunes transcriptional synergy at multi-site promoters, and the germline E318K substitution disrupts this modification to produce a gain-of-function, globally hyper-occupant MITF [PMID:15507434, PMID:22012259, PMID:22080950]; BRAF/MAPK priming followed by GSK3 phosphorylation activates a hydrophobic nuclear export signal [PMID:30150413]; AKT phosphorylation at S510 switches target specificity from tyrosinase toward TP53-CDKN1A [PMID:27702651]; and protein levels are set by UCHL1- and USP13-dependent ubiquitin-proteasome turnover [PMID:28392346, PMID:27869170]. MITF chromatin access at a subset of enhancers requires TFAP2 paralogs acting as pioneer factors [PMID:35580127], and its own transcription is set by p300, MED23, PGC-1α/β, BMAL1, Zeb1, STAT3/CEBP and autorepression [PMID:23201126, PMID:33323974, PMID:30910803, PMID:28834744, PMID:34160901]. Truncating MITF mutations that abolish DNA binding cause Waardenburg syndrome type 2 through haploinsufficiency [PMID:9170159].","teleology":[{"year":1997,"claim":"Established that MITF is an instructive determinant of melanocyte identity and that its disease mutations act through loss of DNA binding rather than dominant interference.","evidence":"Ectopic MITF expression in NIH/3T3 fibroblasts inducing melanocyte markers, plus DNA-binding and tyrosinase reporter assays on WS2 truncation mutants","pmids":["9170159"],"confidence":"High","gaps":["Did not define the endogenous enhancer/promoter network MITF engages","Mechanism of haploinsufficiency dosage sensitivity not resolved"]},{"year":2001,"claim":"Showed MITF is a signal-responsive effector, placing it downstream of M-CSF/MAPK in osteoclast development via phosphorylation-dependent coactivator recruitment.","evidence":"MAPK-site mutagenesis, co-IP with p300, and osteoclast reconstitution in Mitf(mi/mi) bone marrow","pmids":["11684011"],"confidence":"High","gaps":["Did not map all co-occupied promoters","Relationship to other lineage cofactors not addressed"]},{"year":2003,"claim":"Defined direct melanocyte differentiation targets of MITF, anchoring its role in pigment-cell gene expression.","evidence":"EMSA, ChIP, reporter assays and endogenous modulation of SILV and MLANA in melanoma cells","pmids":["12819038"],"confidence":"High","gaps":["Genome-wide target scope not established","Did not address combinatorial enhancer logic"]},{"year":2004,"claim":"Revealed that MITF couples melanocyte differentiation to cell-cycle exit through direct INK4A/p16 activation and Rb cooperation.","evidence":"ChIP, reporter assays, Rb phosphorylation Western blots and differentiation assays (with related p21/Rb1 study in 2005)","pmids":["15623583","15716956"],"confidence":"High","gaps":["Did not reconcile pro-differentiation arrest with proliferative roles in other contexts","Switch between activation and repression of growth genes unexplained"]},{"year":2004,"claim":"Identified SUMOylation and S409 phosphorylation as context-dependent modulators of MITF transcriptional output and cofactor partitioning.","evidence":"SUMO modification and mutagenesis with promoter-context reporter assays; co-IP showing PIAS3 shuttling from MITF to STAT3 in MITF(di/di) mice","pmids":["15507434","15572665"],"confidence":"High","gaps":["The SUMO ligase and deconjugase machinery for MITF not identified","Synergy-control model not tested genome-wide"]},{"year":2006,"claim":"Connected MITF dosage to invasive behavior, showing it activates DIAPH1 and c-Met to control actin dynamics and HGF-dependent invasion.","evidence":"Reporter/ChIP assays, knockdown and overexpression, dominant-negative MITF, and matrix/cell invasion assays in melanoma cells","pmids":["17182868","16455654"],"confidence":"High","gaps":["Quantitative dose thresholds for the invasive switch not defined","Did not integrate with repressed pro-invasion targets identified later"]},{"year":2011,"claim":"Linked the germline E318K variant to a SUMO-defective gain-of-function MITF with expanded genome occupancy, providing a molecular basis for melanoma predisposition.","evidence":"SUMO assays, ChIP and genome-wide occupancy profiling, and clonogenicity/migration/invasion assays across two independent reports","pmids":["22012259","22080950"],"confidence":"High","gaps":["Why loss of a single SUMO site globally increases occupancy mechanistically unresolved","Cooperating genetic events not defined"]},{"year":2015,"claim":"Expanded MITF function beyond transcription into organelle biology, showing it drives endolysosomal biogenesis that amplifies Wnt signaling in a feedback loop.","evidence":"Inducible MITF expression, late-endosomal immunofluorescence, Wnt reporter assays and C-terminal GSK3 phosphosite mapping","pmids":["25605940"],"confidence":"High","gaps":["Whether MVB sequestration generalizes beyond melanoma not tested","Stoichiometry of destruction-complex sequestration unknown"]},{"year":2018,"claim":"Defined the dual-phosphorylation export switch and the structural/karyophilic determinants of MITF localization and stability.","evidence":"Phosphosite mapping, mutagenesis and nuclear export assays (BRAF priming + GSK3); NLS mapping and stability assays of bHLH-Zip mutants","pmids":["30150413","29938923"],"confidence":"High","gaps":["Export receptor recognizing the hydrophobic signal not identified","mTOR-controlled export of non-melanocyte isoforms not mechanistically dissected"]},{"year":2019,"claim":"Resolved the structural basis of CLEAR-box recognition and established MITF as a direct controller of lysosomal/autophagosomal gene programs and starvation autophagy.","evidence":"Crystal structure of MITF on the CLEAR-box, ChIP-seq, and autophagy flux assays with knockdown/overexpression","pmids":["30705290"],"confidence":"High","gaps":["Overexpression alone insufficient for autophagic flux—the limiting cofactor unidentified","Relationship to TFE family redundancy not addressed"]},{"year":2019,"claim":"Implicated MITF in metabolic control through autorepression, SDHB regulation, and HIF1α-dependent co-regulation of hypoxia targets.","evidence":"ChIP-seq, hypoxia gene-expression profiling, metabolite measurement and knockdown/overexpression","pmids":["31207090"],"confidence":"Medium","gaps":["Single-lab study not independently confirmed","Direct mechanism of autorepression not structurally defined"]},{"year":2021,"claim":"Established MITF as a driver of immune evasion, directly activating ADAM10 to shed NK ligands, and refined its repressive control over ECM/adhesion programs.","evidence":"ChIP-seq/qPCR with CRISPR editing of the MITF binding site and NK cytotoxicity assays (ADAM10); ChIP-seq and focal-adhesion quantification for repressed targets","pmids":["33789714","33438577"],"confidence":"High","gaps":["In vivo contribution of ADAM10 axis to immune escape not quantified","Co-repressors mediating ECM-gene silencing not identified"]},{"year":2022,"claim":"Identified TFAP2A/C as pioneer factors required for MITF chromatin access at a subset of enhancers, explaining context-dependent target selection.","evidence":"TFAP2A/C knockout with MITF/TFAP2 ChIP-seq, ATAC-seq, H3K27Ac/H3K27Me3 profiling and gene-expression analysis","pmids":["35580127"],"confidence":"High","gaps":["Which enhancers require TFAP2 versus other pioneers not fully cataloged","Mechanism of cooperative loading at the nucleosome unresolved"]},{"year":null,"claim":"How the many upstream inputs (SUMO state, MAPK/GSK3/AKT phosphorylation, ubiquitin turnover, pioneer-factor availability, and signal-driven transcription) are integrated to set MITF dosage and direct activation versus repression at specific loci genome-wide remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of how PTM combinations encode target specificity","Quantitative dose-response defining rheostat thresholds not established","Degree of redundancy with TFE family proteins in human cells not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[7,11,33]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,4,7,21,22,33]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[9,13,25]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[9,25]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[7,11,21,22,33]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1,4]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[11,25]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[5,6,33]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21]}],"complexes":[],"partners":["RB1","PIAS3","STAT3","EP300","TFAP2A","TFAP2C","TP53","CTNNB1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"O75030","full_name":"Microphthalmia-associated transcription factor","aliases":["Class E basic helix-loop-helix protein 32","bHLHe32"],"length_aa":526,"mass_kda":58.8,"function":"Transcription factor that acts as a master regulator of melanocyte survival and differentiation as well as melanosome biogenesis (PubMed:10587587, PubMed:22647378, PubMed:27889061, PubMed:9647758). Binds to M-boxes (5'-TCATGTG-3') and symmetrical DNA sequences (E-boxes) (5'-CACGTG-3') found in the promoter of pigmentation genes, such as tyrosinase (TYR) (PubMed:10587587, PubMed:22647378, PubMed:27889061, PubMed:9647758). Involved in the cellular response to amino acid availability by acting downstream of MTOR: in the presence of nutrients, MITF phosphorylation by MTOR promotes its inactivation (PubMed:36608670). Upon starvation or lysosomal stress, inhibition of MTOR induces MITF dephosphorylation, resulting in transcription factor activity (PubMed:36608670). Plays an important role in melanocyte development by regulating the expression of tyrosinase (TYR) and tyrosinase-related protein 1 (TYRP1) (PubMed:10587587, PubMed:22647378, PubMed:27889061, PubMed:9647758). Plays a critical role in the differentiation of various cell types, such as neural crest-derived melanocytes, mast cells, osteoclasts and optic cup-derived retinal pigment epithelium (PubMed:10587587, PubMed:22647378, PubMed:27889061, PubMed:9647758)","subcellular_location":"Nucleus; Cytoplasm; Lysosome membrane","url":"https://www.uniprot.org/uniprotkb/O75030/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MITF","classification":"Not Classified","n_dependent_lines":36,"n_total_lines":1208,"dependency_fraction":0.029801324503311258},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MITF","total_profiled":1310},"omim":[{"mim_id":"617306","title":"COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD","url":"https://www.omim.org/entry/617306"},{"mim_id":"616895","title":"SURVIVAL-ASSOCIATED MITOCHONDRIAL MELANOMA-SPECIFIC ONCOGENIC NONCODING RNA; SAMMSON","url":"https://www.omim.org/entry/616895"},{"mim_id":"616637","title":"TBC1 DOMAIN FAMILY, MEMBER 16; TBC1D16","url":"https://www.omim.org/entry/616637"},{"mim_id":"615729","title":"STRAWBERRY NOTCH, DROSOPHILA, HOMOLOG OF, 2; SBNO2","url":"https://www.omim.org/entry/615729"},{"mim_id":"614456","title":"MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8","url":"https://www.omim.org/entry/614456"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MITF"},"hgnc":{"alias_symbol":["MI","bHLHe32"],"prev_symbol":["WS2A","WS2"]},"alphafold":{"accession":"O75030","domains":[{"cath_id":"1.20.5","chopping":"288-338","consensus_level":"medium","plddt":88.2386,"start":288,"end":338},{"cath_id":"1.20.5","chopping":"348-404","consensus_level":"medium","plddt":96.8204,"start":348,"end":404}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O75030","model_url":"https://alphafold.ebi.ac.uk/files/AF-O75030-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O75030-F1-predicted_aligned_error_v6.png","plddt_mean":60.78},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MITF","jax_strain_url":"https://www.jax.org/strain/search?query=MITF"},"sequence":{"accession":"O75030","fasta_url":"https://rest.uniprot.org/uniprotkb/O75030.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O75030/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O75030"}},"corpus_meta":[{"pmid":"16899407","id":"PMC_16899407","title":"MITF: master regulator of melanocyte development and melanoma oncogene.","date":"2006","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16899407","citation_count":868,"is_preprint":false},{"pmid":"17182868","id":"PMC_17182868","title":"Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.","date":"2006","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/17182868","citation_count":477,"is_preprint":false},{"pmid":"22012259","id":"PMC_22012259","title":"A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22012259","citation_count":422,"is_preprint":false},{"pmid":"22080950","id":"PMC_22080950","title":"A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/22080950","citation_count":351,"is_preprint":false},{"pmid":"31123060","id":"PMC_31123060","title":"MITF-the first 25 years.","date":"2019","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/31123060","citation_count":322,"is_preprint":false},{"pmid":"15716956","id":"PMC_15716956","title":"Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15716956","citation_count":308,"is_preprint":false},{"pmid":"25433395","id":"PMC_25433395","title":"MITF in melanoma: mechanisms behind its expression and activity.","date":"2014","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/25433395","citation_count":253,"is_preprint":false},{"pmid":"15020045","id":"PMC_15020045","title":"Mi-2/NuRD: multiple complexes for many purposes.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15020045","citation_count":244,"is_preprint":false},{"pmid":"12819038","id":"PMC_12819038","title":"MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.","date":"2003","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12819038","citation_count":233,"is_preprint":false},{"pmid":"10952390","id":"PMC_10952390","title":"MITF: a stream flowing for pigment cells.","date":"2000","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/10952390","citation_count":226,"is_preprint":false},{"pmid":"15623583","id":"PMC_15623583","title":"MITF links differentiation with cell cycle arrest in melanocytes by transcriptional activation of INK4A.","date":"2004","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15623583","citation_count":198,"is_preprint":false},{"pmid":"25605940","id":"PMC_25605940","title":"MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/25605940","citation_count":196,"is_preprint":false},{"pmid":"21996743","id":"PMC_21996743","title":"Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.","date":"2011","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/21996743","citation_count":156,"is_preprint":false},{"pmid":"11764295","id":"PMC_11764295","title":"Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation.","date":"2001","source":"The journal of investigative dermatology. Symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/11764295","citation_count":152,"is_preprint":false},{"pmid":"16455654","id":"PMC_16455654","title":"c-Met expression is regulated by Mitf in the melanocyte lineage.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16455654","citation_count":143,"is_preprint":false},{"pmid":"17403683","id":"PMC_17403683","title":"MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17403683","citation_count":142,"is_preprint":false},{"pmid":"11543618","id":"PMC_11543618","title":"Duplicate mitf genes in zebrafish: complementary expression and conservation of melanogenic potential.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11543618","citation_count":139,"is_preprint":false},{"pmid":"16129781","id":"PMC_16129781","title":"Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation.","date":"2005","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16129781","citation_count":135,"is_preprint":false},{"pmid":"15507434","id":"PMC_15507434","title":"Sumoylation of MITF and its related family members TFE3 and TFEB.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15507434","citation_count":134,"is_preprint":false},{"pmid":"11684011","id":"PMC_11684011","title":"Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice.","date":"2001","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/11684011","citation_count":129,"is_preprint":false},{"pmid":"22511888","id":"PMC_22511888","title":"Mutations in MITF and PAX3 cause \"splashed white\" and other white spotting phenotypes in horses.","date":"2012","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22511888","citation_count":116,"is_preprint":false},{"pmid":"30019545","id":"PMC_30019545","title":"MITF and UV responses in skin: From pigmentation to addiction.","date":"2018","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/30019545","citation_count":112,"is_preprint":false},{"pmid":"9466887","id":"PMC_9466887","title":"Role of Mitf in differentiation and transdifferentiation of chicken pigmented epithelial cell.","date":"1998","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9466887","citation_count":106,"is_preprint":false},{"pmid":"26761346","id":"PMC_26761346","title":"Drosophila Mitf regulates the V-ATPase and the lysosomal-autophagic pathway.","date":"2016","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/26761346","citation_count":92,"is_preprint":false},{"pmid":"23201126","id":"PMC_23201126","title":"PGC-1 coactivators regulate MITF and the tanning response.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/23201126","citation_count":85,"is_preprint":false},{"pmid":"21519923","id":"PMC_21519923","title":"Regulation of melanocyte pivotal transcription factor MITF by some other transcription factors.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21519923","citation_count":84,"is_preprint":false},{"pmid":"15715979","id":"PMC_15715979","title":"Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform.","date":"2005","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/15715979","citation_count":80,"is_preprint":false},{"pmid":"25142731","id":"PMC_25142731","title":"Pro-survival role of MITF in melanoma.","date":"2014","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25142731","citation_count":79,"is_preprint":false},{"pmid":"30705290","id":"PMC_30705290","title":"MITF has a central role in regulating starvation-induced autophagy in melanoma.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30705290","citation_count":78,"is_preprint":false},{"pmid":"35682684","id":"PMC_35682684","title":"MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35682684","citation_count":73,"is_preprint":false},{"pmid":"26003288","id":"PMC_26003288","title":"The MITF family of transcription factors: Role in endolysosomal biogenesis, Wnt signaling, and oncogenesis.","date":"2015","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/26003288","citation_count":73,"is_preprint":false},{"pmid":"25789707","id":"PMC_25789707","title":"MITF Modulates Therapeutic Resistance through EGFR Signaling.","date":"2015","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25789707","citation_count":72,"is_preprint":false},{"pmid":"9870544","id":"PMC_9870544","title":"A big gene linked to small eyes encodes multiple Mitf isoforms: many promoters make light work.","date":"1998","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9870544","citation_count":71,"is_preprint":false},{"pmid":"33438577","id":"PMC_33438577","title":"MITF reprograms the extracellular matrix and focal adhesion in melanoma.","date":"2021","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/33438577","citation_count":70,"is_preprint":false},{"pmid":"30150413","id":"PMC_30150413","title":"BRAF/MAPK and GSK3 signaling converges to control MITF nuclear export.","date":"2018","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/30150413","citation_count":65,"is_preprint":false},{"pmid":"11764294","id":"PMC_11764294","title":"Cochlear melanocytes and MITF signaling.","date":"2001","source":"The journal of investigative dermatology. Symposium proceedings","url":"https://pubmed.ncbi.nlm.nih.gov/11764294","citation_count":64,"is_preprint":false},{"pmid":"21273305","id":"PMC_21273305","title":"KIT signaling regulates MITF expression through miRNAs in normal and malignant mast cell proliferation.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21273305","citation_count":63,"is_preprint":false},{"pmid":"18983539","id":"PMC_18983539","title":"Gpnmb is a melanoblast-expressed, MITF-dependent gene.","date":"2008","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/18983539","citation_count":61,"is_preprint":false},{"pmid":"9170159","id":"PMC_9170159","title":"Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A.","date":"1997","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/9170159","citation_count":58,"is_preprint":false},{"pmid":"34233163","id":"PMC_34233163","title":"NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/34233163","citation_count":55,"is_preprint":false},{"pmid":"15572665","id":"PMC_15572665","title":"Interplay between MITF, PIAS3, and STAT3 in mast cells and melanocytes.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15572665","citation_count":55,"is_preprint":false},{"pmid":"31207090","id":"PMC_31207090","title":"MITF controls the TCA cycle to modulate the melanoma hypoxia response.","date":"2019","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/31207090","citation_count":55,"is_preprint":false},{"pmid":"19515996","id":"PMC_19515996","title":"Zeb1 represses Mitf and regulates pigment synthesis, cell proliferation, and epithelial morphology.","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/19515996","citation_count":52,"is_preprint":false},{"pmid":"33323974","id":"PMC_33323974","title":"STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33323974","citation_count":52,"is_preprint":false},{"pmid":"7687937","id":"PMC_7687937","title":"Amiodarone and post-MI patients.","date":"1993","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/7687937","citation_count":51,"is_preprint":false},{"pmid":"31242455","id":"PMC_31242455","title":"The transcription factor MITF in RPE function and dysfunction.","date":"2019","source":"Progress in retinal and eye research","url":"https://pubmed.ncbi.nlm.nih.gov/31242455","citation_count":50,"is_preprint":false},{"pmid":"18922793","id":"PMC_18922793","title":"UV radiation regulates Mi-2 through protein translation and stability.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18922793","citation_count":50,"is_preprint":false},{"pmid":"28607030","id":"PMC_28607030","title":"miRNA-340 inhibits osteoclast differentiation via repression of MITF.","date":"2017","source":"Bioscience reports","url":"https://pubmed.ncbi.nlm.nih.gov/28607030","citation_count":50,"is_preprint":false},{"pmid":"30910803","id":"PMC_30910803","title":"MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/30910803","citation_count":49,"is_preprint":false},{"pmid":"27869170","id":"PMC_27869170","title":"Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals.","date":"2016","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/27869170","citation_count":49,"is_preprint":false},{"pmid":"27580416","id":"PMC_27580416","title":"HMGB1 Inhibits Apoptosis Following MI and Induces Autophagy via mTORC1 Inhibition.","date":"2016","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27580416","citation_count":49,"is_preprint":false},{"pmid":"28883623","id":"PMC_28883623","title":"MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28883623","citation_count":48,"is_preprint":false},{"pmid":"20807369","id":"PMC_20807369","title":"The discovery of the microphthalmia locus and its gene, Mitf.","date":"2010","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/20807369","citation_count":47,"is_preprint":false},{"pmid":"23787126","id":"PMC_23787126","title":"MITF mutations associated with pigment deficiency syndromes and melanoma have different effects on protein function.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23787126","citation_count":47,"is_preprint":false},{"pmid":"28880216","id":"PMC_28880216","title":"Inhibition of NAT10 Suppresses Melanogenesis and Melanoma Growth by Attenuating Microphthalmia-Associated Transcription Factor (MITF) Expression.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28880216","citation_count":47,"is_preprint":false},{"pmid":"14737107","id":"PMC_14737107","title":"STAT3 and MITF cooperatively induce cellular transformation through upregulation of c-fos expression.","date":"2004","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/14737107","citation_count":44,"is_preprint":false},{"pmid":"30290719","id":"PMC_30290719","title":"MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress.","date":"2018","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/30290719","citation_count":43,"is_preprint":false},{"pmid":"16162175","id":"PMC_16162175","title":"MITF and cell proliferation: the role of alternative splice forms.","date":"2005","source":"Pigment cell research","url":"https://pubmed.ncbi.nlm.nih.gov/16162175","citation_count":42,"is_preprint":false},{"pmid":"21771814","id":"PMC_21771814","title":"Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in Mitf.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21771814","citation_count":42,"is_preprint":false},{"pmid":"31582381","id":"PMC_31582381","title":"Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.","date":"2019","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/31582381","citation_count":38,"is_preprint":false},{"pmid":"34093521","id":"PMC_34093521","title":"Mitf Involved in Innate Immunity by Activating Tyrosinase-Mediated Melanin Synthesis in Pteria penguin.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34093521","citation_count":37,"is_preprint":false},{"pmid":"29181082","id":"PMC_29181082","title":"SOX10-MITF pathway activity in melanoma cells.","date":"2016","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/29181082","citation_count":36,"is_preprint":false},{"pmid":"29496358","id":"PMC_29496358","title":"MITF-M regulates melanogenesis in mouse melanocytes.","date":"2018","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/29496358","citation_count":35,"is_preprint":false},{"pmid":"23414473","id":"PMC_23414473","title":"MITF, the Janus transcription factor of melanoma.","date":"2013","source":"Future oncology (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23414473","citation_count":35,"is_preprint":false},{"pmid":"27185926","id":"PMC_27185926","title":"BPTF transduces MITF-driven prosurvival signals in melanoma cells.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27185926","citation_count":34,"is_preprint":false},{"pmid":"11919417","id":"PMC_11919417","title":"Regulation of mast cell phenotype by MITF.","date":"2002","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11919417","citation_count":33,"is_preprint":false},{"pmid":"33051548","id":"PMC_33051548","title":"Cancer risks associated with the germline MITF(E318K) variant.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33051548","citation_count":33,"is_preprint":false},{"pmid":"27702651","id":"PMC_27702651","title":"Phosphorylation of MITF by AKT affects its downstream targets and causes TP53-dependent cell senescence.","date":"2016","source":"The international journal of biochemistry & cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27702651","citation_count":33,"is_preprint":false},{"pmid":"17266927","id":"PMC_17266927","title":"Role of microphthalmia transcription factor (Mitf) in melanoma differentiation.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17266927","citation_count":33,"is_preprint":false},{"pmid":"35580127","id":"PMC_35580127","title":"TFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes.","date":"2022","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/35580127","citation_count":32,"is_preprint":false},{"pmid":"35107169","id":"PMC_35107169","title":"A review of neoplasms with MITF/MiT family translocations.","date":"2022","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/35107169","citation_count":30,"is_preprint":false},{"pmid":"28825724","id":"PMC_28825724","title":"Pathways from senescence to melanoma: focus on MITF sumoylation.","date":"2017","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/28825724","citation_count":30,"is_preprint":false},{"pmid":"25152440","id":"PMC_25152440","title":"Mitf regulates osteoclastogenesis by modulating NFATc1 activity.","date":"2014","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/25152440","citation_count":30,"is_preprint":false},{"pmid":"24062982","id":"PMC_24062982","title":"MITF and PAX3 Play Distinct Roles in Melanoma Cell Migration; Outline of a \"Genetic Switch\" Theory Involving MITF and PAX3 in Proliferative and Invasive Phenotypes of Melanoma.","date":"2013","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24062982","citation_count":29,"is_preprint":false},{"pmid":"28923400","id":"PMC_28923400","title":"MITF suppression improves the sensitivity of melanoma cells to a BRAF inhibitor.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28923400","citation_count":29,"is_preprint":false},{"pmid":"28392346","id":"PMC_28392346","title":"UCHL1 Regulates Melanogenesis through Controlling MITF Stability in Human Melanocytes.","date":"2017","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/28392346","citation_count":29,"is_preprint":false},{"pmid":"24290354","id":"PMC_24290354","title":"A germline oncogenic MITF mutation and tumor susceptibility.","date":"2013","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24290354","citation_count":27,"is_preprint":false},{"pmid":"12217380","id":"PMC_12217380","title":"The function of MITF and associated proteins in mast cells.","date":"2002","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12217380","citation_count":27,"is_preprint":false},{"pmid":"26599548","id":"PMC_26599548","title":"miR-211 and MITF modulation by Bcl-2 protein in melanoma cells.","date":"2015","source":"Molecular carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/26599548","citation_count":27,"is_preprint":false},{"pmid":"30502589","id":"PMC_30502589","title":"Microphthalmia-Associated Transcription Factor (MITF) Regulates Immune Cell Migration into Melanoma.","date":"2018","source":"Translational oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30502589","citation_count":27,"is_preprint":false},{"pmid":"29938923","id":"PMC_29938923","title":"Subcellular localization and stability of MITF are modulated by the bHLH-Zip domain.","date":"2018","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/29938923","citation_count":25,"is_preprint":false},{"pmid":"33441180","id":"PMC_33441180","title":"The underestimated role of the microphthalmia-associated transcription factor (MiTF) in normal and pathological haematopoiesis.","date":"2021","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/33441180","citation_count":25,"is_preprint":false},{"pmid":"33789714","id":"PMC_33789714","title":"MITF induces escape from innate immunity in melanoma.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/33789714","citation_count":23,"is_preprint":false},{"pmid":"19659611","id":"PMC_19659611","title":"Simultaneous suppression of MITF and BRAF V600E enhanced inhibition of melanoma cell proliferation.","date":"2009","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/19659611","citation_count":23,"is_preprint":false},{"pmid":"32881934","id":"PMC_32881934","title":"MITF and TFEB cross-regulation in melanoma cells.","date":"2020","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/32881934","citation_count":22,"is_preprint":false},{"pmid":"33389492","id":"PMC_33389492","title":"Involvement of adenylate cyclase/cAMP/CREB and SOX9/MITF in melanogenesis to prevent vitiligo.","date":"2021","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33389492","citation_count":22,"is_preprint":false},{"pmid":"34160901","id":"PMC_34160901","title":"Circadian clock protein BMAL1 regulates melanogenesis through MITF in melanoma cells.","date":"2021","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/34160901","citation_count":21,"is_preprint":false},{"pmid":"17457519","id":"PMC_17457519","title":"Expression and transcriptional activity of alternative splice variants of Mitf exon 6.","date":"2007","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17457519","citation_count":21,"is_preprint":false},{"pmid":"29167580","id":"PMC_29167580","title":"Pyridoxamine improves survival and limits cardiac dysfunction after MI.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29167580","citation_count":21,"is_preprint":false},{"pmid":"31562697","id":"PMC_31562697","title":"Delineating the role of MITF isoforms in pigmentation and tissue homeostasis.","date":"2019","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/31562697","citation_count":20,"is_preprint":false},{"pmid":"37057373","id":"PMC_37057373","title":"Clear cell tumor with melanocytic differentiation and MITF::CREM translocation.","date":"2023","source":"Journal of cutaneous pathology","url":"https://pubmed.ncbi.nlm.nih.gov/37057373","citation_count":20,"is_preprint":false},{"pmid":"28158928","id":"PMC_28158928","title":"Baicalin positively regulates osteoclast function by activating MAPK/Mitf signalling.","date":"2017","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28158928","citation_count":20,"is_preprint":false},{"pmid":"35996507","id":"PMC_35996507","title":"Mi-RNA-93 and Mi-RNA-152 in the Diagnosis of Type 2 Diabetes and Diabetic Retinopathy.","date":"2022","source":"British journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/35996507","citation_count":19,"is_preprint":false},{"pmid":"24519885","id":"PMC_24519885","title":"Enhancement of RANKL-induced MITF-E expression and osteoclastogenesis by TGF-β.","date":"2014","source":"Cell biochemistry and function","url":"https://pubmed.ncbi.nlm.nih.gov/24519885","citation_count":19,"is_preprint":false},{"pmid":"30549420","id":"PMC_30549420","title":"A homozygous MITF mutation leads to familial Waardenburg syndrome type 4.","date":"2018","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30549420","citation_count":19,"is_preprint":false},{"pmid":"32728090","id":"PMC_32728090","title":"MITF variants cause nonsyndromic sensorineural hearing loss with autosomal recessive inheritance.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32728090","citation_count":19,"is_preprint":false},{"pmid":"31595650","id":"PMC_31595650","title":"ABCB5 is activated by MITF and β-catenin and is associated with melanoma differentiation.","date":"2019","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/31595650","citation_count":18,"is_preprint":false},{"pmid":"28834744","id":"PMC_28834744","title":"Mediator MED23 Links Pigmentation and DNA Repair through the Transcription Factor MITF.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28834744","citation_count":18,"is_preprint":false},{"pmid":"15108314","id":"PMC_15108314","title":"Isolation and developmental expression of Mitf in Xenopus laevis.","date":"2004","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/15108314","citation_count":18,"is_preprint":false},{"pmid":"34356645","id":"PMC_34356645","title":"Endolysosomal Cation Channels and MITF in Melanocytes and Melanoma.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/34356645","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":46109,"output_tokens":8973,"usd":0.136461,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18897,"output_tokens":4646,"usd":0.105317,"stage2_stop_reason":"end_turn"},"total_usd":0.241778,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2006,\n      \"finding\": \"MITF directly transcriptionally activates the DIAPH1 gene encoding the formin Dia1, which promotes actin polymerization. Low MITF levels reduce Dia1 expression, reorganize the actin cytoskeleton, and increase ROCK-dependent invasiveness; high MITF expression decreases invasiveness. Additionally, MITF regulation of Dia1 controls p27(Kip1)-dependent G1 arrest, linking MITF to both invasiveness and proliferation control.\",\n      \"method\": \"Transcriptional reporter assays, siRNA knockdown, overexpression in melanoma cells, cell invasion assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean KD/OE with defined cellular phenotype, multiple orthogonal readouts (actin reorganization, p27 degradation, ROCK-dependent invasion) in a single focused study\",\n      \"pmids\": [\"17182868\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MITF acts as an anti-proliferative transcription factor by directly activating the p21(Cip1)/CDKN1A cyclin-dependent kinase inhibitor gene, inducing G1 cell-cycle arrest. Cooperation between MITF and the retinoblastoma protein Rb1 potentiates MITF-mediated transcriptional activation, and this cooperation is disrupted by melanoma-associated mutations in INK4a or BRAF.\",\n      \"method\": \"Transcriptional reporter assays, ChIP, loss-of-function/gain-of-function in melanocytes and melanoma cells, cell cycle analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal functional assays, ChIP validation, multiple orthogonal methods, replicated concept across multiple studies\",\n      \"pmids\": [\"15716956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MITF is subject to SUMO modification at conserved lysine residues within SUMO consensus sites. Mutation of these sites significantly affects transcriptional activity of MITF but does not alter dimerization, DNA binding, stability, or nuclear localization. The functional consequences of sumoylation depend on promoter context (synergy control model): differences in transcriptional activity between wild-type and non-sumoylatable MITF are seen only on promoters with multiple MITF binding sites.\",\n      \"method\": \"SUMO modification assays, mutagenesis of sumoylation sites, luciferase reporter assays, dimerization and DNA-binding assays in vitro\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with in vitro binding assays and reporter assays, multiple orthogonal methods in a single focused study\",\n      \"pmids\": [\"15507434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"A germline missense substitution in MITF (E318K) located within a SUMO consensus site severely impairs SUMOylation of MITF. The SUMOylation-defective Mi-E318K mutant shows enhanced MITF protein binding to the HIF1A promoter, increased transcriptional activity, and a global increase in MITF-occupied loci compared to wild-type MITF, consistent with a gain-of-function mechanism.\",\n      \"method\": \"SUMO modification assays, ChIP, gene expression profiling, clonogenicity/migration/invasion assays in cell lines\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — biochemical SUMO assay, ChIP, functional cellular assays, two independent publications (PMID 22012259 and 22080950) confirming E318K impairs sumoylation\",\n      \"pmids\": [\"22012259\", \"22080950\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"MITF directly binds the INK4A (CDKN2A) promoter, activates p16(Ink4a) mRNA and protein expression, induces retinoblastoma protein hypophosphorylation, and thereby triggers cell cycle arrest. MITF-driven INK4A activation was required for efficient melanocyte differentiation, linking melanocyte differentiation to cell cycle exit through MITF.\",\n      \"method\": \"ChIP, luciferase reporter assays, MITF overexpression/knockdown, Western blot for Rb phosphorylation, differentiation assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP validation plus functional rescue/loss-of-function with defined cell cycle readout, multiple orthogonal methods\",\n      \"pmids\": [\"15623583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"M-CSF/macrophage colony-stimulating factor induces phosphorylation of Mitf and TFE3 via a conserved MAPK consensus site, triggering their recruitment of the coactivator p300. An unphosphorylatable Mitf mutant at the MAPK consensus serine specifically fails to support formation of multinucleated osteoclasts, mimicking the defect in Mitf(mi/mi) mice, placing Mitf downstream of M-CSF signaling in osteoclast development.\",\n      \"method\": \"Phosphorylation assays, co-immunoprecipitation with p300, mutagenesis, osteoclast differentiation assays in Mitf(mi/mi) bone marrow cultures\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis of phosphorylation site with clear phenotypic readout, co-IP with p300, functional reconstitution in osteoclast model\",\n      \"pmids\": [\"11684011\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"MITF and PU.1 co-occupy promoters of osteoclast target genes (e.g., cathepsin K, acid phosphatase 5) in bone marrow-derived precursors in response to CSF-1. RANKL + CSF-1 signaling recruits MAPK-phosphorylated forms of MITF, p38 MAPK, and SWI/SNF chromatin-remodeling complexes to these promoters and markedly increases gene expression. NFATc1 is subsequently recruited to these complexes during terminal osteoclast differentiation.\",\n      \"method\": \"ChIP, co-immunoprecipitation, genetic analysis in Mitf and Pu.1 mutant mice, gene expression assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP at endogenous promoters, reciprocal co-IP, genetic mouse models, multiple orthogonal methods\",\n      \"pmids\": [\"17403683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"MITF directly transcriptionally regulates the melanoma diagnostic antigens SILV/PMEL17/GP100 and MLANA/MART1. Both gene promoters contain conserved MITF consensus DNA sequences that are bound by MITF in vitro (EMSA) and in vivo (ChIP), and up- or down-regulation of MITF produces corresponding changes in endogenous SILV and MLANA expression.\",\n      \"method\": \"EMSA, ChIP, luciferase reporter assays, siRNA knockdown and overexpression of MITF in melanoma cells\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and EMSA plus functional reporter assays and endogenous gene modulation, multiple orthogonal methods\",\n      \"pmids\": [\"12819038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"c-Met (HGF receptor) is a direct transcriptional target of MITF. MITF binds the human c-Met promoter in vivo (ChIP) and adenovirally expressed MITF modulates endogenous c-Met protein levels in melanocytes. Disruption of MITF blocked HGF-dependent increases in c-Met mRNA/protein, indicating HGF regulates its own receptor levels via MITF. Dominant-negative inhibition of MITF resulted in resistance to HGF-dependent matrix invasion.\",\n      \"method\": \"ChIP, adenoviral overexpression, MITF dominant-negative constructs, matrix invasion assays, Western blot\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and functional genetic manipulation with defined invasion phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"16455654\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BRAF/MAPK signaling phosphorylates the melanocyte MITF-M isoform, which primes for subsequent phosphorylation by GSK3 (downstream of PI3K and Wnt). Dual phosphorylation (but not monophosphorylation) promotes MITF nuclear export by activating a previously unrecognized hydrophobic export signal. Non-melanocyte MITF isoforms show poor regulation by MAPK but their export is controlled by mTOR.\",\n      \"method\": \"Phosphorylation mapping, mutagenesis, nuclear export assays, kinase inhibitor treatments, mass spectrometry\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — mutagenesis combined with nuclear export assays and MS-based phosphorylation mapping, multiple orthogonal methods\",\n      \"pmids\": [\"30150413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MITF expression drives endolysosomal biogenesis in melanoma cells by upregulating lysosomal genes. This leads to a marked increase in multivesicular body (MVB) formation that sequesters the Wnt destruction complex (Axin1, phospho-LRP6, phospho-β-catenin, GSK3) upon Wnt stimulation, enhancing Wnt signaling. MITF protein is stabilized by Wnt signaling through novel C-terminal GSK3 phosphorylation sites, generating a positive feedback loop.\",\n      \"method\": \"Tetracycline-inducible MITF expression, immunofluorescence for late endosomal proteins, Wnt reporter assays, phosphorylation mapping, colocalization studies\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible expression system, vesicle characterization, Wnt reporter assays, multiple orthogonal methods in one study\",\n      \"pmids\": [\"25605940\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MITF binds the CLEAR-box element in the promoters of lysosomal and autophagosomal genes in melanocytes and melanoma cells. Crystal structure of MITF bound to the CLEAR-box reveals that the palindromic nature of this motif induces symmetric MITF homodimer binding. Depletion of MITF attenuates starvation-induced autophagy, while overexpression increases autophagosome numbers but is insufficient to induce autophagic flux.\",\n      \"method\": \"Crystal structure determination, ChIP-seq, MITF knockdown and overexpression, autophagy flux assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — crystal structure with functional ChIP validation and loss/gain-of-function autophagy phenotype, multiple orthogonal methods\",\n      \"pmids\": [\"30705290\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In mast cells stimulated via gp130 receptor, MITF is phosphorylated at S409. This phosphorylation of MITF leads to PIAS3 dissociation from MITF and association of PIAS3 with STAT3, mobilizing PIAS3 from MITF to STAT3. In MITF(di/di) mice lacking the Zip domain (the PIAS3-binding domain of MITF), mRNA levels of genes regulated by either MITF or STAT3 are downregulated.\",\n      \"method\": \"Phosphorylation assays, co-immunoprecipitation, genetic analysis in MITF(di/di) mice, gene expression assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — co-IP demonstrating protein complex dynamics with phosphorylation, genetic validation in mutant mice, multiple orthogonal methods\",\n      \"pmids\": [\"15572665\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The bHLH-Zip domain of MITF-M contains three karyophilic signals (residues 197–206, 214–217, 255–265). Neither DNA binding nor dimerization is required for nuclear localization of MITF-M. Dimerization-deficient MITF-M mutants show significantly reduced stability in melanoma cells compared to wild-type protein, indicating the bHLH-Zip domain modulates both subcellular localization and protein stability.\",\n      \"method\": \"Mutational analysis of nuclear localization signals, structural characterization, nuclear localization assays, protein stability assays in melanoma cells\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic mutagenesis with structural analysis, but single lab study\",\n      \"pmids\": [\"29938923\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"KIT signaling in mast cells markedly upregulates MITF protein without significantly changing MITF mRNA levels, indicating posttranscriptional regulation. KIT signaling downregulates miR-539 and miR-381, miRNAs that repress MITF expression through conserved binding sites in the MITF 3'-UTR. MITF is required for the proliferative phenotype in mast cells, as shRNA knockdown inhibited colony-forming activity.\",\n      \"method\": \"miRNA array, luciferase 3'-UTR reporter assays, miRNA overexpression, shRNA knockdown, colony-forming assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — 3'-UTR reporter validation of miRNA targeting, functional knockdown with colony formation readout, multiple orthogonal methods\",\n      \"pmids\": [\"21273305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MITF directly activates BPTF gene transcription by binding to the BPTF promoter (validated by ChIP), and MITF overexpression upregulates BPTF and BPTF-regulated genes including BCL2. Suppression of cell growth mediated by MITF silencing is rescued by overexpression of BPTF cDNA, placing BPTF downstream of MITF in the pro-survival signaling cascade.\",\n      \"method\": \"ChIP, luciferase reporter assays, MITF overexpression and shRNA knockdown, rescue experiment with BPTF cDNA\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP combined with functional rescue experiment and reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"27185926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PGC-1α and PGC-1β coactivators are critical for α-MSH–induced MITF expression in melanocytes. α-MSH signaling strongly induces PGC-1α expression and stabilizes both PGC-1α and PGC-1β proteins, which in turn directly activate the MITF promoter. Inhibition of PGC-1α and PGC-1β blocks α-MSH–mediated induction of MITF and melanogenic genes.\",\n      \"method\": \"PGC-1 overexpression and siRNA knockdown, MITF promoter reporter assays, α-MSH stimulation, gene expression analysis, transgenic animals\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter reporter assays combined with in vivo transgenic validation and loss-of-function, multiple orthogonal methods\",\n      \"pmids\": [\"23201126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"AKT phosphorylates MITF at Serine 510. Phosphorylated MITF-S510 enhances its affinity for TP53 and promotes CDKN1A (p21) expression. Non-phosphorylated MITF promotes TYR (tyrosinase) expression instead, revealing a bifunctional switch in MITF target gene regulation depending on AKT activity.\",\n      \"method\": \"Kinase assays, co-immunoprecipitation, mutagenesis of S510, luciferase reporter assays, Western blot\",\n      \"journal\": \"The international journal of biochemistry & cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — co-IP and mutagenesis establishing phosphorylation-dependent binding, single lab, single study\",\n      \"pmids\": [\"27702651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"MITF directly represses its own transcription (autorepression) and directly regulates SDHB to control the TCA cycle and suppress pseudo-hypoxia. Under hypoxia, MITF is transiently upregulated by HIF1α and co-regulates a subset of HIF targets including VEGFA.\",\n      \"method\": \"ChIP-seq, gene expression analysis under hypoxia, knockdown/overexpression of MITF, metabolite measurement\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP-seq and functional gene regulation studies, single lab, single publication\",\n      \"pmids\": [\"31207090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UCHL1 negatively regulates MITF protein stability by binding to ubiquitinated MITF and promoting its proteasomal degradation. UCHL1 knockdown upregulates MITF protein (but not mRNA), and proteasome inhibitor MG132 prevents UCHL1-mediated MITF reduction. UCHL1 overexpression suppresses MITF-dependent melanogenesis genes.\",\n      \"method\": \"siRNA knockdown, adenoviral overexpression, proteasome inhibitor treatment, co-immunoprecipitation of ubiquitinated MITF, Western blot\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — co-IP with ubiquitinated MITF and proteasome inhibitor rescue, single lab, single study\",\n      \"pmids\": [\"28392346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Androgen receptor (AR) promotes MITF protein degradation through modulation of the miRNA-539-3p/USP13 signaling axis; AR reduces de-ubiquitination of MITF by decreasing USP13 activity via miRNA-539-3p, leading to decreased MITF levels, which shifts the MITF/AXL balance and promotes melanoma cell invasion. Restoring MITF reverses AR-enhanced invasion.\",\n      \"method\": \"AR and USP13 manipulation, MITF protein stability assays, ubiquitination assays, invasion assays, rescue experiments\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ubiquitination and stability assays with functional rescue, single lab, single study\",\n      \"pmids\": [\"27869170\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MITF directly transcriptionally activates ADAM10 (a sheddase that cleaves MICA/B NK cell ligands), as established by ChIP-seq, ChIP-qPCR, CRISPR-Cas9 editing of the MITF binding site, and luciferase reporter assays. High MITF-expressing melanoma cells escape NK cell killing by shedding MICA/B via ADAM10, whereas MITF-low cells are susceptible to NK-mediated killing.\",\n      \"method\": \"ChIP-seq, ChIP-qPCR, CRISPR-Cas9 genome editing, luciferase reporter assays, flow cytometry, NK cytotoxicity assays\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP with CRISPR-Cas9 editing of binding site and functional NK killing assay, multiple rigorous orthogonal methods\",\n      \"pmids\": [\"33789714\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MITF directly represses the expression of genes associated with extracellular matrix (ECM) remodeling, focal adhesion pathways, and EMT regulators such as CDH2 in melanoma cells. MITF knockdown increases the number of focal adhesion points, a feature of drug-resistant melanomas. These effects are reversible, consistent with the MITF rheostat model.\",\n      \"method\": \"MITF knockdown, ChIP-seq for direct repression targets, focal adhesion quantification, gene expression profiling, morphology analysis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP-seq confirming direct binding at repressed genes, multiple orthogonal phenotypic readouts\",\n      \"pmids\": [\"33438577\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"TFAP2 paralogs (TFAP2A and TFAP2C) are required for MITF binding and chromatin accessibility at a subset of enhancers near pigmentation and proliferation genes in melanoma cells. Deletion of TFAP2A and TFAP2C abolishes MITF chromatin binding at co-operative enhancers, reduces H3K27Ac marks, and impairs MITF-driven activation of pigmentation genes, revealing TFAP2 as a pioneer factor for MITF.\",\n      \"method\": \"TFAP2A/C knockout, ChIP-seq for MITF and TFAP2A, ATAC-seq for chromatin accessibility, H3K27Ac and H3K27Me3 ChIP-seq, gene expression analysis\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — combinatorial ChIP-seq and ATAC-seq in knockout cells with multiple orthogonal epigenomic methods\",\n      \"pmids\": [\"35580127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"STAT3 suppresses MITF transcription through induction of CEBP family member transcription factors (CEBPa/b), which bind to the MITF enhancer region and silence the MITF locus. ATAC-seq confirmed CEBPa/b binding at the MITF enhancer causes epigenetic silencing. Loss of STAT3 in mouse melanoma leads to upregulation of MITF and reduced metastasis.\",\n      \"method\": \"Conditional Stat3 knockout in mouse melanoma, whole-genome expression profiling, ATAC-seq, 3D melanoma models, CEBP ChIP-seq\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout combined with ATAC-seq and transcriptomics, multiple orthogonal methods\",\n      \"pmids\": [\"33323974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"MITF-MIR211 constitutes a feed-forward autophagy amplification loop. Under stress (starvation or mTOR inhibition), MITF translocates to the nucleus and upregulates MIR211. MIR211 directly targets RICTOR (an mTORC2 component), inhibiting the mTORC1 pathway, which further stimulates MITF nuclear translocation, completing a positive feedback loop that sustains autophagic activity.\",\n      \"method\": \"mTOR inhibition and starvation assays, MITF nuclear translocation imaging, MIR211 overexpression, luciferase 3'-UTR reporter assay for RICTOR, autophagy flux assays\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — 3'-UTR reporter and functional assays, single lab, single study\",\n      \"pmids\": [\"30290719\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"p300 histone acetyltransferase directly controls MITF transcription through histone acetylation within proximal MITF gene regulatory regions in melanoma cells. Targeted chemical inhibition of p300 acetyltransferase activity suppresses MITF expression and reduces melanoma cell proliferation. FOXM1 was identified as a key downstream effector of the p300-MITF axis.\",\n      \"method\": \"p300 genetic and chemical inhibition, ChIP for histone acetylation at MITF locus, gene expression analysis, proliferation assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP validation of p300-dependent histone acetylation at MITF locus, single lab, single study\",\n      \"pmids\": [\"30910803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Zeb1 transcription factor binds the Mitf-A promoter in vivo (ChIP) and represses Mitf expression. Heterozygous Zeb1 mutation or shRNA knockdown prevents Mitf repression during RPE dedifferentiation, thereby maintaining Mitf expression and pigmented epithelial morphology. This identifies a regulatory axis linking cell-cell contact signals to Mitf via Zeb1.\",\n      \"method\": \"ChIP at Mitf-A promoter, Zeb1 heterozygous mouse model, lentiviral shRNA knockdown, RT-PCR, cell morphology analysis\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating Zeb1 occupancy at Mitf promoter in vivo with genetic validation, moderate evidence\",\n      \"pmids\": [\"19515996\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"STAT3 and MITF cooperatively bind and upregulate the c-fos promoter in NIH-3T3 cells, leading to anchorage-independent growth (cellular transformation). ChIP confirmed both STAT3 and MITF bind the c-fos promoter, and dominant-negative AP-1 (c-fos/c-jun) suppressed transformation by STAT3C + MITF.\",\n      \"method\": \"Retroviral cDNA library screen, promoter luciferase assays, ChIP, soft-agar colony assays, dominant-negative AP-1 suppression\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and functional reporter assays with rescue experiment, single lab, moderate strength\",\n      \"pmids\": [\"14737107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MITF directly regulates the ABCB5 transporter gene, with β-catenin acting as a key activator and co-factor for MITF at the ABCB5 locus. ABCB5 expression is primarily associated with melanoma cells exhibiting differentiation markers (MITF-high state), contrary to its previous characterization as a dedifferentiated stem cell marker.\",\n      \"method\": \"ChIP, β-catenin co-activation assays, gene expression analysis in melanoma cell lines\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP validation, single lab, single study\",\n      \"pmids\": [\"31595650\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The Mediator subunit MED23 controls MITF expression by modulating a distal MITF enhancer. Loss of Med23 impairs pigmentation in melanocyte lineage cells and in zebrafish, and enhances nucleotide excision repair (NER) by de-repressing NER factor expression, revealing that the MED23/MITF axis couples DNA repair to pigmentation.\",\n      \"method\": \"Med23 knockout, MITF enhancer reporter assays, ChIP for NER factors, zebrafish pigmentation rescue, UV DNA damage assays\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with enhancer reporter and in vivo zebrafish validation, multiple orthogonal methods\",\n      \"pmids\": [\"28834744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"BMAL1 (circadian clock protein) binds the promoter region of MITF and transcriptionally regulates its expression in a rhythmic (24-hr periodicity) manner. BMAL1-driven MITF expression positively influences melanin synthesis and BMAL1 overexpression increases melanin levels that protect melanoma cells from UVB-mediated DNA damage.\",\n      \"method\": \"Circadian synchronization, ChIP at MITF promoter, BMAL1 overexpression, melanin quantification, UVB damage assays\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — ChIP validation and functional overexpression, single lab, single study\",\n      \"pmids\": [\"34160901\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"MITF splice isoforms containing exon 6a (the alternatively spliced hexapeptide upstream of the DNA-binding basic domain) have stronger inhibitory effects on DNA synthesis than isoforms lacking exon 6a. The anti-proliferative activity of (+)MITF depends on the aminoterminus and is modulated by serine-73 phosphorylation, and is not dependent on direct E-box binding.\",\n      \"method\": \"BrdU incorporation assays, FACS cell cycle analysis, transient transfection of MITF isoform mutants, mutagenesis of phosphorylation sites\",\n      \"journal\": \"Pigment cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis combined with functional cell cycle assays, but single lab\",\n      \"pmids\": [\"16162175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Ectopic MITF expression converts NIH/3T3 fibroblasts into cells with melanocyte characteristics (dendritic morphology, tyrosinase, TRP-1 expression), demonstrating MITF's instructive role in melanocyte differentiation. WS2-associated truncating mutations in MITF lose DNA-binding activity and fail to transactivate the tyrosinase promoter, but do not show dominant-negative effects on wild-type MITF activity, supporting haploinsufficiency as the disease mechanism.\",\n      \"method\": \"Transfection of MITF and mutants into NIH/3T3 fibroblasts, melanocyte marker expression, DNA-binding assays, luciferase reporter assays\",\n      \"journal\": \"Pigment cell research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — ectopic expression with differentiation marker readout and functional characterization of disease mutants, foundational study confirmed by multiple later papers\",\n      \"pmids\": [\"9170159\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MITF is a bHLH-Zip transcription factor that functions as a master regulator of the melanocyte lineage by directly activating or repressing target gene promoters through E-box/CLEAR-box binding; its activity is tightly controlled by post-translational modifications including MAPK-primed GSK3 phosphorylation (triggering nuclear export via a hydrophobic export signal), SUMOylation at a conserved ΨKXE site (modulating transcriptional synergy at multi-site promoters via synergy control), AKT phosphorylation at S510 (switching target specificity toward TP53-CDKN1A), S409 phosphorylation (triggering PIAS3 dissociation and redistribution to STAT3), M-CSF/MAPK phosphorylation (recruiting the p300 coactivator for osteoclast gene expression), and ubiquitin-proteasome-mediated degradation regulated by UCHL1 and USP13; MITF drives cell cycle exit by transcriptionally activating p21(Cip1) and p16(INK4A), controls invasiveness by activating the formin DIAPH1/Dia1, regulates lysosomal biogenesis and starvation-induced autophagy through CLEAR-element target genes and a MITF-MIR211 feed-forward loop, escapes innate immune killing via direct transactivation of ADAM10, and requires TFAP2 paralogs as pioneer factors for chromatin access at a subset of its target enhancers.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MITF is a basic-helix-loop-helix leucine-zipper (bHLH-Zip) transcription factor that acts as a master regulator of the melanocyte lineage and a broader rheostat of cell state, capable of instructively converting fibroblasts into pigment-producing cells with melanocyte morphology and marker expression [#33]. It binds E-box/CLEAR-box consensus sequences as a homodimer—the palindromic CLEAR-box inducing symmetric dimer binding [#11]—to directly activate melanocyte differentiation genes including SILV/PMEL17 and MLANA [#7], the receptor c-Met [#8], and the transporter ABCB5 in cooperation with \\u03b2-catenin [#29]. MITF couples differentiation to cell-cycle exit by directly activating the CDK inhibitors p21(Cip1)/CDKN1A (potentiated by Rb1) and p16(INK4A), driving Rb hypophosphorylation and G1 arrest [#1, #4], and controls invasiveness by activating the formin DIAPH1/Dia1 to remodel the actin cytoskeleton and limit ROCK-dependent invasion [#0] while directly repressing ECM-remodeling and EMT genes such as CDH2 [#22], consistent with a reversible rheostat model of melanoma phenotype switching. Beyond pigment cells, MITF directs lysosomal/autophagosomal biogenesis through CLEAR-box targets and sustains starvation-induced autophagy via a MITF-MIR211-RICTOR feed-forward loop [#11, #25], promotes endolysosomal sequestration of the Wnt destruction complex to amplify Wnt signaling [#10], and functions downstream of M-CSF/RANKL signaling in osteoclast differentiation by cooperating with PU.1, NFATc1 and SWI/SNF [#5, #6]. MITF activity is governed by an extensive post-translational and transcriptional control network: SUMOylation at a conserved consensus site tunes transcriptional synergy at multi-site promoters, and the germline E318K substitution disrupts this modification to produce a gain-of-function, globally hyper-occupant MITF [#2, #3]; BRAF/MAPK priming followed by GSK3 phosphorylation activates a hydrophobic nuclear export signal [#9]; AKT phosphorylation at S510 switches target specificity from tyrosinase toward TP53-CDKN1A [#17]; and protein levels are set by UCHL1- and USP13-dependent ubiquitin-proteasome turnover [#19, #20]. MITF chromatin access at a subset of enhancers requires TFAP2 paralogs acting as pioneer factors [#23], and its own transcription is set by p300, MED23, PGC-1\\u03b1/\\u03b2, BMAL1, Zeb1, STAT3/CEBP and autorepression [#16, #24, #26, #30, #31]. Truncating MITF mutations that abolish DNA binding cause Waardenburg syndrome type 2 through haploinsufficiency [#33].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Established that MITF is an instructive determinant of melanocyte identity and that its disease mutations act through loss of DNA binding rather than dominant interference.\",\n      \"evidence\": \"Ectopic MITF expression in NIH/3T3 fibroblasts inducing melanocyte markers, plus DNA-binding and tyrosinase reporter assays on WS2 truncation mutants\",\n      \"pmids\": [\"9170159\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the endogenous enhancer/promoter network MITF engages\", \"Mechanism of haploinsufficiency dosage sensitivity not resolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Showed MITF is a signal-responsive effector, placing it downstream of M-CSF/MAPK in osteoclast development via phosphorylation-dependent coactivator recruitment.\",\n      \"evidence\": \"MAPK-site mutagenesis, co-IP with p300, and osteoclast reconstitution in Mitf(mi/mi) bone marrow\",\n      \"pmids\": [\"11684011\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map all co-occupied promoters\", \"Relationship to other lineage cofactors not addressed\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Defined direct melanocyte differentiation targets of MITF, anchoring its role in pigment-cell gene expression.\",\n      \"evidence\": \"EMSA, ChIP, reporter assays and endogenous modulation of SILV and MLANA in melanoma cells\",\n      \"pmids\": [\"12819038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide target scope not established\", \"Did not address combinatorial enhancer logic\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Revealed that MITF couples melanocyte differentiation to cell-cycle exit through direct INK4A/p16 activation and Rb cooperation.\",\n      \"evidence\": \"ChIP, reporter assays, Rb phosphorylation Western blots and differentiation assays (with related p21/Rb1 study in 2005)\",\n      \"pmids\": [\"15623583\", \"15716956\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not reconcile pro-differentiation arrest with proliferative roles in other contexts\", \"Switch between activation and repression of growth genes unexplained\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified SUMOylation and S409 phosphorylation as context-dependent modulators of MITF transcriptional output and cofactor partitioning.\",\n      \"evidence\": \"SUMO modification and mutagenesis with promoter-context reporter assays; co-IP showing PIAS3 shuttling from MITF to STAT3 in MITF(di/di) mice\",\n      \"pmids\": [\"15507434\", \"15572665\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The SUMO ligase and deconjugase machinery for MITF not identified\", \"Synergy-control model not tested genome-wide\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Connected MITF dosage to invasive behavior, showing it activates DIAPH1 and c-Met to control actin dynamics and HGF-dependent invasion.\",\n      \"evidence\": \"Reporter/ChIP assays, knockdown and overexpression, dominant-negative MITF, and matrix/cell invasion assays in melanoma cells\",\n      \"pmids\": [\"17182868\", \"16455654\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative dose thresholds for the invasive switch not defined\", \"Did not integrate with repressed pro-invasion targets identified later\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked the germline E318K variant to a SUMO-defective gain-of-function MITF with expanded genome occupancy, providing a molecular basis for melanoma predisposition.\",\n      \"evidence\": \"SUMO assays, ChIP and genome-wide occupancy profiling, and clonogenicity/migration/invasion assays across two independent reports\",\n      \"pmids\": [\"22012259\", \"22080950\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Why loss of a single SUMO site globally increases occupancy mechanistically unresolved\", \"Cooperating genetic events not defined\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Expanded MITF function beyond transcription into organelle biology, showing it drives endolysosomal biogenesis that amplifies Wnt signaling in a feedback loop.\",\n      \"evidence\": \"Inducible MITF expression, late-endosomal immunofluorescence, Wnt reporter assays and C-terminal GSK3 phosphosite mapping\",\n      \"pmids\": [\"25605940\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether MVB sequestration generalizes beyond melanoma not tested\", \"Stoichiometry of destruction-complex sequestration unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined the dual-phosphorylation export switch and the structural/karyophilic determinants of MITF localization and stability.\",\n      \"evidence\": \"Phosphosite mapping, mutagenesis and nuclear export assays (BRAF priming + GSK3); NLS mapping and stability assays of bHLH-Zip mutants\",\n      \"pmids\": [\"30150413\", \"29938923\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Export receptor recognizing the hydrophobic signal not identified\", \"mTOR-controlled export of non-melanocyte isoforms not mechanistically dissected\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Resolved the structural basis of CLEAR-box recognition and established MITF as a direct controller of lysosomal/autophagosomal gene programs and starvation autophagy.\",\n      \"evidence\": \"Crystal structure of MITF on the CLEAR-box, ChIP-seq, and autophagy flux assays with knockdown/overexpression\",\n      \"pmids\": [\"30705290\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Overexpression alone insufficient for autophagic flux—the limiting cofactor unidentified\", \"Relationship to TFE family redundancy not addressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Implicated MITF in metabolic control through autorepression, SDHB regulation, and HIF1\\u03b1-dependent co-regulation of hypoxia targets.\",\n      \"evidence\": \"ChIP-seq, hypoxia gene-expression profiling, metabolite measurement and knockdown/overexpression\",\n      \"pmids\": [\"31207090\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab study not independently confirmed\", \"Direct mechanism of autorepression not structurally defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Established MITF as a driver of immune evasion, directly activating ADAM10 to shed NK ligands, and refined its repressive control over ECM/adhesion programs.\",\n      \"evidence\": \"ChIP-seq/qPCR with CRISPR editing of the MITF binding site and NK cytotoxicity assays (ADAM10); ChIP-seq and focal-adhesion quantification for repressed targets\",\n      \"pmids\": [\"33789714\", \"33438577\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo contribution of ADAM10 axis to immune escape not quantified\", \"Co-repressors mediating ECM-gene silencing not identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified TFAP2A/C as pioneer factors required for MITF chromatin access at a subset of enhancers, explaining context-dependent target selection.\",\n      \"evidence\": \"TFAP2A/C knockout with MITF/TFAP2 ChIP-seq, ATAC-seq, H3K27Ac/H3K27Me3 profiling and gene-expression analysis\",\n      \"pmids\": [\"35580127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which enhancers require TFAP2 versus other pioneers not fully cataloged\", \"Mechanism of cooperative loading at the nucleosome unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the many upstream inputs (SUMO state, MAPK/GSK3/AKT phosphorylation, ubiquitin turnover, pioneer-factor availability, and signal-driven transcription) are integrated to set MITF dosage and direct activation versus repression at specific loci genome-wide remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of how PTM combinations encode target specificity\", \"Quantitative dose-response defining rheostat thresholds not established\", \"Degree of redundancy with TFE family proteins in human cells not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [7, 11, 33]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 4, 7, 21, 22, 33]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [9, 13, 25]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [9, 25]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [7, 11, 21, 22, 33]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [11, 25]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [5, 6, 33]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"RB1\", \"PIAS3\", \"STAT3\", \"EP300\", \"TFAP2A\", \"TFAP2C\", \"TP53\", \"CTNNB1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}